Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v4-FR
Language English French
Date Updated 2020-09-17 2020-09-15
Drug Identification Number 02456575 02456575
Brand name SYNJARDY SYNJARDY
Common or Proper name Synjardy 5/500mg, 6x10s Tablets Synjardy 5/500mg, 6x10s Tablets
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Ingredients EMPAGLIFLOZIN METFORMIN HYDROCHLORIDE EMPAGLIFLOZIN METFORMIN HYDROCHLORIDE
Strength(s) 5MG 500MG 5MG 500MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size Blister Pack 6x10 Blister Pack 6x10
ATC code A10BD A10BD
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-09-16 2020-09-16
Actual start date
Estimated end date 2020-10-13 2020-10-13
Actual end date
Shortage status Actual shortage Anticipated shortage
Company comments
Health Canada comments